Search or

𝛼SK

ENTITY

Mycenax Biotech (4726 TT)

Health Care • Taiwan

Mycenax Biotech Inc. develops and manufactures biopharmaceutical products derived from mammalian cell culture and microbial fermentation.

more

Refresh

Exchange Announcement • 25 Nov 2025 18:04

The Company’S Board Of Directors Approved The Execution Of The Shareholders Agreement.

Exchange Announcement • 10 Nov 2025 16:20

Announcement Of The Capital Increase Record Date For The Conversion Of Employee Stock Options To Common Stocks.

Exchange Announcement • 10 Nov 2025 16:20

The Board Of Directors Approved The Consolidated Financial Statements For The Third Quarter Of 2025

Exchange Announcement • 31 Oct 2025 17:41

Announcement For The Expected Date Of The Board Of Directors Meeting For 2025 3rd Quarter Financial Statements Is 2025/11/10

Exchange Announcement • 02 Oct 2025 17:09

The Company’S Board Of Directors Authorized The Chairman To Execute The “Non-Binding Term Sheet On Joint Venture Agreement”.

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x